1. Home
  2. TLSA vs ELA Comparison

TLSA vs ELA Comparison

Compare TLSA & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • ELA
  • Stock Information
  • Founded
  • TLSA 2013
  • ELA 1965
  • Country
  • TLSA United Kingdom
  • ELA United States
  • Employees
  • TLSA N/A
  • ELA N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • ELA Consumer Specialties
  • Sector
  • TLSA Health Care
  • ELA Consumer Discretionary
  • Exchange
  • TLSA Nasdaq
  • ELA Nasdaq
  • Market Cap
  • TLSA 187.0M
  • ELA 190.1M
  • IPO Year
  • TLSA 2000
  • ELA N/A
  • Fundamental
  • Price
  • TLSA $1.66
  • ELA $7.55
  • Analyst Decision
  • TLSA
  • ELA Strong Buy
  • Analyst Count
  • TLSA 0
  • ELA 1
  • Target Price
  • TLSA N/A
  • ELA $9.00
  • AVG Volume (30 Days)
  • TLSA 369.4K
  • ELA 56.1K
  • Earning Date
  • TLSA 05-06-2025
  • ELA 11-04-2025
  • Dividend Yield
  • TLSA N/A
  • ELA N/A
  • EPS Growth
  • TLSA N/A
  • ELA 34.09
  • EPS
  • TLSA N/A
  • ELA 0.33
  • Revenue
  • TLSA N/A
  • ELA $198,354,109.00
  • Revenue This Year
  • TLSA N/A
  • ELA $14.43
  • Revenue Next Year
  • TLSA N/A
  • ELA $2.60
  • P/E Ratio
  • TLSA N/A
  • ELA $22.84
  • Revenue Growth
  • TLSA N/A
  • ELA 24.35
  • 52 Week Low
  • TLSA $0.63
  • ELA $4.90
  • 52 Week High
  • TLSA $2.60
  • ELA $7.88
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 40.76
  • ELA 66.13
  • Support Level
  • TLSA $1.73
  • ELA $7.29
  • Resistance Level
  • TLSA $1.90
  • ELA $7.78
  • Average True Range (ATR)
  • TLSA 0.15
  • ELA 0.33
  • MACD
  • TLSA -0.05
  • ELA 0.01
  • Stochastic Oscillator
  • TLSA 24.19
  • ELA 76.53

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About ELA Envela Corporation

Envela Corp is a provider of recycling and re-commerce services at the forefront of the circular economy. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.

Share on Social Networks: